Works matching IS 10196439 AND DT 2022 AND VI 60 AND IP 2
Results: 11
Extracellular domain of semaphorin 5A serves a tumor-suppressing role by activating interferon signaling pathways in lung adenocarcinoma cells.
- Published in:
- International Journal of Oncology, 2022, v. 60, n. 2, p. N.PAG, doi. 10.3892/ijo.2022.5311
- By:
- Publication type:
- Article
Overexpression of Parkin in clear cell renal cell carcinoma decreases tumor aggressiveness by regulating CKS2 levels.
- Published in:
- International Journal of Oncology, 2022, v. 60, n. 2, p. N.PAG, doi. 10.3892/ijo.2022.5310
- By:
- Publication type:
- Article
Epigallocatechin-3-gallate hinders metabolic coupling to suppress colorectal cancer malignancy through targeting aerobic glycolysis in cancer-associated fibroblasts.
- Published in:
- International Journal of Oncology, 2022, v. 60, n. 2, p. N.PAG, doi. 10.3892/ijo.2022.5309
- By:
- Publication type:
- Article
Arsenic compounds induce apoptosis by activating the MAPK and caspase pathways in FaDu oral squamous carcinoma cells.
- Published in:
- International Journal of Oncology, 2022, v. 60, n. 2, p. N.PAG, doi. 10.3892/ijo.2022.5308
- By:
- Publication type:
- Article
Obesity, colorectal cancer and MACC1 expression: A possible novel molecular association.
- Published in:
- International Journal of Oncology, 2022, v. 60, n. 2, p. N.PAG, doi. 10.3892/ijo.2022.5307
- By:
- Publication type:
- Article
Protein disulfide isomerase A1-associated pathways in the development of stratified breast cancer therapies.
- Published in:
- International Journal of Oncology, 2022, v. 60, n. 2, p. N.PAG, doi. 10.3892/ijo.2022.5306
- By:
- Publication type:
- Article
LRIG2 promotes the proliferation and cell cycle progression of glioblastoma cells in vitro and in vivo through enhancing PDGFRβ signaling.
- Published in:
- International Journal of Oncology, 2022, v. 60, n. 2, p. N.PAG, doi. 10.3892/ijo.2022.5305
- By:
- Publication type:
- Article
N6-methyladenosine upregulates miR-181d-5p in exosomes derived from cancer-associated fibroblasts to inhibit 5-FU sensitivity by targeting NCALD in colorectal cancer.
- Published in:
- International Journal of Oncology, 2022, v. 60, n. 2, p. N.PAG, doi. 10.3892/ijo.2022.5304
- By:
- Publication type:
- Article
Retrospective analysis of the preparation and application of immunotherapy in cancer treatment (Review).
- Published in:
- International Journal of Oncology, 2022, v. 60, n. 2, p. N.PAG, doi. 10.3892/ijo.2022.5302
- By:
- Publication type:
- Article
Receptor for activated C kinase 1 (RACK1) promotes the progression of OSCC via the AKT/mTOR pathway.
- Published in:
- International Journal of Oncology, 2022, v. 60, n. 2, p. N.PAG, doi. 10.3892/ijo.2022.5301
- By:
- Publication type:
- Article
Functional assessment of miR-1291 in colon cancer cells.
- Published in:
- International Journal of Oncology, 2022, v. 60, n. 2, p. N.PAG, doi. 10.3892/ijo.2022.5303
- By:
- Publication type:
- Article